Tag: License Agreement

October 1, 2018

Melinta Therapeutics and Menarini Group Enter Commercial Agreement

Melinta Therapeutics (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, and Menarini Group,...
September 28, 2018
September 27, 2018

DiaMedica Therapeutics and Ahon Pharma Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke

Ahon Pharmaceutical a subsidiary of Shanghai Fosun Pharmaceutical (HKG:02196,SHA:600196) and DiaMedica Therapeutics (TSXV:DMA,OTCQB:DMCAF) entered into a license and collaboration agreement,...
August 20, 2018

RedHill BioPharma Receives New Patent

RedHill Biopharma received a notice of allowance from the US Patent and Trademark Office on Monday for a new formulation...
August 7, 2018

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE (plecanatide) in China

Synergy Pharmaceuticals (NASDAQ:SGYP) announced today that the company has entered into a license agreement with Luoxin Pharmaceutical Group Shandong (Luoxin)...
July 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack

resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...